Back to Journals » Clinical Ophthalmology » Volume 13

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab

Total article views   Abstract views HTML views PDF downloads Totals
6,227 Dovepress* 4,773 459+ 1,383 5,232
PubMed Central* 0 995 155 995
Totals 4,773 1,454 1,538 6,227
*Since 19 December 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar